Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
for
ERα+ Breast Cancer, ESR1 Gene Mutation
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 19+
Code: NCT04174352
Early Phase 1, Recruiting
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: Madison WI, Ann Arbor MI, New Brunswick NJ, New York NY
Sponsor: Genta Incorporated
Sex: Male
Age: 18+
Code: NCT01296243
Phase 2, Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Madison WI, Milwaukee WI, Chicago IL, Rochester MN,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase 1, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Madison WI, Chicago IL, Iowa City IA, Rochester MN,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase 2, Phase 3, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Madison WI, New York NY, Aurora CO, Boston MA,
Sponsor: I-Mab Biopharma US Limited
Sex: All
Age: 18+
Code: NCT04900818
Phase 1, Recruiting
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
for
Prostate Cancer, Malignant Neoplasm of Prostate,
Location: Madison WI, Cleveland OH, New York NY
Sponsor: Case Comprehensive Cancer Center
Sex: Male
Age: 18+
Code: NCT06150417
Phase 2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Madison WI, Chicago IL, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
SPEARHEAD-3 Pediatric Study
for
Synovial Sarcoma,
Location: Madison WI, St Louis MO, Cincinnati OH, Bethesda MD,
Sponsor: USWM CT, LLC
Sex: All
Age: 2 - 21
Code: NCT05642455
Phase 1, Phase 2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Madison WI, Milwaukee WI, Sheboygan WI, La Crosse WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Madison WI, Washington DC, Baltimore MD, Durham NC,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
for
Metastatic Colorectal Carcinoma,
Location: Madison WI, Chicago IL, Rochester MN, Grand Rapids MI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT05863195
Phase 3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Madison WI, Park Ridge IL, Hinsdale IL, Peoria IL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Location: Madison WI, Springfield IL, Minneapolis MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 7+
Code: NCT05705531
Recruiting
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Madison WI, Chicago IL, Columbus OH, Lexington KY,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT05691465
Phase 2, Recruiting
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
for
Metastatic Malignant Solid Neoplasm,
Location: Madison WI, Chicago IL, Columbus OH, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687110
Phase 1, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Madison WI, Iowa City IA, Rochester MN, St Louis MO,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase 1, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Madison WI, Chicago IL, Iowa City IA, Rochester MN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
for
Prostate Cancer
Location: Madison WI, DeKalb IL, Geneva IL, Warrenville IL,
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 21+
Code: NCT03151629
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Madison WI, Chicago IL, Iowa City IA, Ann Arbor MI,